The global anti-inflammatory biologics market size is expected to reach USD 149.80 billion by 2027, exhibiting a CAGR of 11.0% during the forecast period. The indication of an inflammatory surplus in patients with COVID-19 along with plentiful neutrophils and macrophages will revivify growth prospects for the anti-inflammatory biologics market share during the forecast period. The ongoing trials for anti-tumor necrosis factor (TNF) antibodies in severe cases of autoimmune inflammatory disease such as rheumatoid arthritis, inflammatory bowel disease, or ankylosing spondylitis will aid the speedy expansion of the market during the forecast period, mentioned by Fortune Business Insights Please visit: https://www.fortunebusinessinsights.com/anti-inflammatory-biologics-market-102733 Anti-Inflammatory Biologics Market Size, Share & Industry Analysis, By Drug Class (Anti-Tumor Necrosis Factor (TNF), Interleukin Antagonists, Janus Kinase (JAK) Inhibitors, Others), By Application (Rheumatoid Arthritis, Psoriasis, and Others), By Route of Administration (Oral and Injection (Subcutaneous and Intravenous)), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027” the market size stood at USD 64.84 billion in 2019. Increasing Cases of Inflammatory Diseases to Boost Growth in North America The market in North America stood at USD 28.63 billion in 2019. The growth of the region is attributed to rising government support for the introduction of biosimilars in the region. The potential pipeline candidates along with demand for anti-TNF drugs will aid healthy growth of the market in the region. The increasing prevalence of rheumatoid arthritis will spur demand for the market in North America Ongoing Trails for Anti-Tumour Necrosis Factor Therapy to Benefit COVID-19 Patients The increasing R&D investments by major players for the development of biologics will promote market growth in the forthcoming years. The rising number of deaths from coronavirus (COVID-19) has steered pharmaceutical companies to invest in potential drug candidates. The growing prominence of TNF in acute inflammatory reactions will have a positive impact on the market More Trending Topics from Fortune Business Insights: https://www.fortunebusinessinsights.com/insulin-pump-market-102735 https://www.fortunebusinessinsights.com/industry-reports/foot-orthotic-insoles-market-100348